Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
Pfizer
Nicolino Ruperto; Hermine I Brunner; Olga Synoverska; Tracy V Ting; Carlos Abud Mendoza; Alberto Spindler; Yulia Vyzhga; Katherine Marzan; Lyudmila Grebenkina; Irit Tirosh; Lisa Imundo; Rita Jerath; Daniel J Kingsbury; Betul Sozeri; Sheetal S Vora; Sampath Prahalad; Elena Zholobova; Yonatan Butbul Aviel; Vyacheslav Chasnyk; Melissa Lerman; Kabita Nanda; Heinrike Schmeling; Heather Tory; Yosef Uziel; Diego O Viola; Holly B Posner; Keith S Kanik; Ann Wouters; Cheng Chang; Richard Zhang; Irina Lazariciu; Ming-Ann Hsu; Ricardo M Suehiro; Alberto Martini; Daniel J Lovell; Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG)